Annual Cash & Cash Equivalents
$21.61 M
-$7.18 M-24.94%
December 31, 2023
Summary
- As of February 26, 2025, APRE annual cash & cash equivalents is $21.61 million, with the most recent change of -$7.18 million (-24.94%) on December 31, 2023.
- During the last 3 years, APRE annual cash & cash equivalents has fallen by -$67.41 million (-75.73%).
- APRE annual cash & cash equivalents is now -83.39% below its all-time high of $130.09 million, reached on December 31, 2019.
Performance
APRE Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$26.25 M
-$2.45 M-8.52%
September 30, 2024
Summary
- As of February 26, 2025, APRE quarterly cash and cash equivalents is $26.25 million, with the most recent change of -$2.45 million (-8.52%) on September 30, 2024.
- Over the past year, APRE quarterly cash and cash equivalents has dropped by -$6.12 million (-18.91%).
- APRE quarterly cash and cash equivalents is now -79.82% below its all-time high of $130.09 million, reached on December 31, 2019.
Performance
APRE Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
APRE Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.9% | -18.9% |
| 3 y3 years | -75.7% | -57.3% |
| 5 y5 years | -67.1% | -49.8% |
APRE Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -59.3% | at low | -50.5% | +21.5% |
| 5 y | 5-year | -83.4% | at low | -79.8% | +21.5% |
| alltime | all time | -83.4% | >+9999.0% | -79.8% | +21.5% |
Aprea Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $26.25 M(-8.5%) |
| Jun 2024 | - | $28.69 M(-11.4%) |
| Mar 2024 | - | $32.37 M(+49.8%) |
| Dec 2023 | $21.61 M(-24.9%) | $21.61 M(-14.8%) |
| Sep 2023 | - | $25.35 M(-8.4%) |
| Jun 2023 | - | $27.69 M(-10.7%) |
| Mar 2023 | - | $31.00 M(+7.7%) |
| Dec 2022 | $28.79 M(-45.8%) | $28.79 M(-13.1%) |
| Sep 2022 | - | $33.11 M(-15.2%) |
| Jun 2022 | - | $39.06 M(-18.0%) |
| Mar 2022 | - | $47.65 M(-10.2%) |
| Dec 2021 | $53.08 M | $53.08 M(-13.6%) |
| Sep 2021 | - | $61.43 M(-12.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $69.80 M(-10.1%) |
| Mar 2021 | - | $77.62 M(-12.8%) |
| Dec 2020 | $89.02 M(-31.6%) | $89.02 M(-12.0%) |
| Sep 2020 | - | $101.15 M(-10.4%) |
| Jun 2020 | - | $112.86 M(-7.9%) |
| Mar 2020 | - | $122.51 M(-5.8%) |
| Dec 2019 | $130.09 M(+98.1%) | $130.09 M(+148.6%) |
| Sep 2019 | - | $52.33 M(-14.2%) |
| Jun 2019 | - | $60.99 M(-7.1%) |
| Dec 2018 | $65.68 M(+169.1%) | $65.68 M |
| Dec 2017 | $24.40 M(>+9900.0%) | - |
| Jun 2008 | $3100.00(-98.3%) | - |
| Jun 2007 | $181.90 K(+19.4%) | - |
| Jun 2006 | $152.30 K | - |
FAQ
- What is Aprea Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Aprea Therapeutics?
- What is Aprea Therapeutics annual cash & cash equivalents year-on-year change?
- What is Aprea Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Aprea Therapeutics?
- What is Aprea Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Aprea Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of APRE is $21.61 M
What is the all time high annual cash & cash equivalents for Aprea Therapeutics?
Aprea Therapeutics all-time high annual cash & cash equivalents is $130.09 M
What is Aprea Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, APRE annual cash & cash equivalents has changed by -$7.18 M (-24.94%)
What is Aprea Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of APRE is $26.25 M
What is the all time high quarterly cash and cash equivalents for Aprea Therapeutics?
Aprea Therapeutics all-time high quarterly cash and cash equivalents is $130.09 M
What is Aprea Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, APRE quarterly cash and cash equivalents has changed by -$6.12 M (-18.91%)